Skip to content

The comparative of Vagiheal Barij® vaginal gel with estromarin cream in vaginal atrophy

The comparative of Vagiheal Barij® vaginal gel with estromarin cream in vaginal atrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190910044736N1
Enrollment
300
Registered
2019-12-04
Start date
2020-02-20
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post menopausal Vaginitis atrophic. Postmenopausal atrophic vaginitis

Interventions

Intervention 1: Intervention group1: Vagiheal gel Barij (Barij essence company), using an applicator (2.5 gram in 7 night)as a first treatment then 2 times in weeks. until 2 months.There is at least

Sponsors

Arak University of Medical Sciences
Lead Sponsor
Barij Essence
Collaborator

Eligibility

Sex/Gender
Female
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Menopausal women with dysparonia itching and pain during intercourse dryness in vagina No abnormal uterus bleeding No diabetes No hypertension No heart diseases No thyroid disease At least two years pasted of menopause

Exclusion criteria

Exclusion criteria: Do not obey protocol treatment

Design outcomes

Primary

MeasureTime frame
The mean of itching , burning ,disparonia and vaginal cell maturation base on Visual Analog Scale 0-10. Timepoint: Three weeks ,one and 2 months after treatment. Method of measurement: Visual Analog Scale 0-10.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKatayon Vakilian

Arak University of Medical Sciences

cattyv2002@yahoo.com+98 86 3417 3505

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026